Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Denis Getsios"'
Autor:
Shien Guo, Denis Getsios, Luis Hernandez, Kelly Cho, Elizabeth Lawler, Arman Altincatal, Stephan Lanes, Michael Blankenburg
Publikováno v:
International Journal of Alzheimer's Disease, Vol 2012 (2012)
The growing understanding of the use of biomarkers in Alzheimer's disease (AD) may enable physicians to make more accurate and timely diagnoses. Florbetaben, a beta-amyloid tracer used with positron emission tomography (PET), is one of these diagnost
Externí odkaz:
https://doaj.org/article/34013724ab764778b9798e458005eaf0
Autor:
Laurent Coudeville, Annelies Van Rie, Denis Getsios, J Jaime Caro, Pascal Crépey, Van Hung Nguyen
Publikováno v:
PLoS ONE, Vol 4, Iss 7, p e6284 (2009)
BACKGROUND: Prior economic evaluations of adult and adolescent vaccination strategies against pertussis have reached disparate conclusions. Using static approaches only, previous studies failed to analytically include the indirect benefits derived fr
Externí odkaz:
https://doaj.org/article/05dd489757144caf828b3cc0ac7538e5
Autor:
Jean Ferrières, Jacques Bénichou, Denis Getsios, Lucien Abenhaim, Luis Hernandez, Lamiae Grimaldi-Bensouda, Michel Rossignol, J. Jaime Caro, Jean Dallongeville
Publikováno v:
Journal of Clinical Lipidology. 10:1379-1388
To evaluate the real-life impact of ezetimibe on cardiovascular (CV) morbidity and mortality in France.To estimate the number of non-fatal and fatal CV events that could be prevented and corresponding number of patients needed to treat (NNT) with eze
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a73377213324449064f03c14d3af217
https://doi.org/10.1016/j.jacl.2016.08.015
https://doi.org/10.1016/j.jacl.2016.08.015
Publikováno v:
PharmacoEconomics. 34:681-707
Numerous economic evaluations using decision-analytic models have assessed the cost effectiveness of treatments for Alzheimer’s disease (AD) in the last two decades. It is important to understand the methods used in the existing models of AD and ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fe4701ff830a979c5437699b9661089
https://doi.org/10.1007/s40273-016-0392-1
https://doi.org/10.1007/s40273-016-0392-1
Autor:
Shien Guo, Maren Gaudig, Joel Bobula, Peng Xu, Loretto Lacey, G. Thompson, Nikhil Revankar, Denis Getsios
Publikováno v:
PharmacoEconomics. 32:1129-1139
Considerable advances have been made in modeling Alzheimer's disease (AD), with a move towards individual-level rather than cohort models and simulations that consider multiple dimensions when evaluating disease severity. However, the possibility tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54c9ba6de158085dec96e7f887e43c96
https://doi.org/10.1007/s40273-014-0203-5
https://doi.org/10.1007/s40273-014-0203-5
Autor:
James G. Xenakis, Richard J. Willke, Jenő P. Marton, K. Jack Ishak, Denis Getsios, Dale Rublee, Alexandra Ward, Nikhil Revankar
Publikováno v:
PharmacoEconomics. 31:767-780
Most existing models of smoking cessation treatments have considered a single quit attempt when modelling long-term outcomes.To develop a model to simulate smokers over their lifetimes accounting for multiple quit attempts and relapses which will all
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15ad5b2181cb7940434bf04c11ebd7d8
https://doi.org/10.1007/s40273-013-0070-5
https://doi.org/10.1007/s40273-013-0070-5
Autor:
Marilyn Stolar, Greg Williams, K. Jack Ishak, Piedad Alvarez, Ming-yi Hu, Tracy Aber Crothers, Yamei Wang, Denis Getsios
Publikováno v:
Expert Opinion on Pharmacotherapy. 14:1285-1293
Perioperative hypertension affects 80% of cardiac surgery patients and is associated with an increased risk of complications.To determine the relationship between perioperative blood pressure (BP) control and hospital costs for cardiac surgery in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae0cee068097e8e5d7f999e505c2298b
https://doi.org/10.1517/14656566.2013.798646
https://doi.org/10.1517/14656566.2013.798646
Publikováno v:
Applied Health Economics and Health Policy. 10:365-379
Economic models are developed to provide decision makers with information related to the real-world effectiveness of therapeutics, screening and diagnostic regimens. Although compliance with these regimens often has a significant impact on real-world
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c52d14123fb572da3913c0ba9248efb9
https://doi.org/10.1007/bf03261872
https://doi.org/10.1007/bf03261872
Publikováno v:
Journal of Medical Economics. 10:239-254
SummaryRimonabant, the first selective CB-1 receptor blocker, is expected to reduce cardiometabolic risk substantially. This study assesses the economics of such treatment in patients at elevated cardiometabolic risk.A Markov model was developed usin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a422b3b2604643224102a062edc20896
https://doi.org/10.3111/13696990701438629
https://doi.org/10.3111/13696990701438629
Publikováno v:
PharmacoEconomics. 25:997-1006
The National Institute for Health and Clinical Excellence (NICE) recently issued updated guidance on the use of cholinesterase inhibitors in the treatment of Alzheimer's disease. NICE initially recommended that cholinesterase inhibitors no longer be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2832b7e34a9abbeea02fc2ea2f39fdc
https://doi.org/10.2165/00019053-200725120-00003
https://doi.org/10.2165/00019053-200725120-00003